共 50 条
- [1] Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (05): : 444 - 450
- [2] Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery [J]. CANCER MEDICINE, 2015, 4 (01): : 1 - 6
- [6] Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery [J]. Journal of Neuro-Oncology, 2024, 166 : 431 - 440
- [7] Ipilimumab and Stereotactic Radiosurgery for Melanoma Brain Metastases [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S115 - S116
- [9] Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases [J]. Journal of Neuro-Oncology, 2017, 132 : 455 - 462
- [10] Repeat stereotactic radiosurgery for locally recurrent brain metastases previously treated with stereotactic radiosurgery: A systematic review and meta-analysis of efficacy and safety [J]. JOURNAL OF RADIOSURGERY AND SBRT, 2022, 8 (01): : 1 - +